Table 2.
SNP | Gene | Location | MEC & Ghana, African | PLCO & BPC3, non-Hispanic white | Heterogeneity c | Meta-regressiond | Interactione | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||
Allelea | EAF | OR (95%CI)b | Pb | Allelea | EAF | OR (95%CI)b | Pb | Q | I2 | P for the racial group | P | |||
6 Top SNPs identified in African Descendants | ||||||||||||||
rs56197129 | TP63 | Intron | C/A | 0.17 | 1.35 (1.15–1.60) | 3.16E-04 | C/A | 0.12 | 1.14 (0.97–1.34) | 0.110 | 0.148 | 52.3 | 0.148 | 0.007 |
rs6795002 | TP63 | Intron | T/A | 0.18 | 1.35 (1.15–1.59) | 2.51E-04 | T/A | 0.13 | 1.14 (0.97–1.34) | 0.114 | 0.142 | 53.6 | 0.142 | 0.006 |
rs55851920 | TP63 | Intron | T/C | 0.17 | 1.36 (1.15–1.60) | 2.77E-04 | T/C | 0.12 | 1.15 (0.98–1.35) | 0.097 | 0.152 | 51.2 | 0.152 | 0.011 |
rs7616437 | TP63 | Intron | A/G | 0.18 | 1.37 (1.16–1.60) | 1.44E-04 | A/G | 0.19 | 1.09 (0.87–1.36) | 0.461 | 0.106 | 61.7 | 0.080 | 0.004 |
rs722921f | ALDH1A1 | Intron | T/A | 0.18 | 0.73 (0.61–0.88) | 0.001 | A/T | 0.46 | 1.00 (0.83–1.21) | 0.991 | 0.019 | 81.7 | 0.033 | 0.032 |
rs855723 | WNT1 | 5′-Upstream | A/G | 0.48 | 1.26 (1.10–1.43) | 0.001 | A/G | 0.15 | 1.04 (0.90–1.22) | 0.589 | 0.067 | 70.1 | 0.067 | 0.040 |
8 Top SNPs identified in Non-Hispanic Whites | ||||||||||||||
rs2072454 | EGFR | Exon-Synonymous | T/C | 0.51 | 0.89 (0.72–1.10) | 0.285 | T/C | 0.48 | 1.23 (1.10–1.37) | 2.66E-04 | 0.009 | 85.6 | 0.012 | 0.001 |
rs2270247 | EGFR | Intron | T/G | 0.50 | 0.89 (0.73–1.10) | 0.293 | T/G | 0.48 | 1.23 (1.10–1.37) | 2.47E-04 | 0.008 | 85.6 | 0.012 | 0.001 |
rs730437 | EGFR | Intron | C/A | 0.51 | 0.89 (0.73–1.10) | 0.291 | C/A | 0.48 | 1.23 (1.10–1.37) | 2.47E-04 | 0.008 | 85.7 | 0.012 | 0.001 |
rs2075109 | EGFR | Intron | C/T | 0.45 | 0.98 (0.86–1.11) | 0.755 | C/T | 0.48 | 1.23 (1.11–1.37) | 1.74E-04 | 0.007 | 86.0 | 0.016 | 0.024 |
rs2075110 | EGFR | Intron | T/C | 0.37 | 0.96 (0.84–1.09) | 0.506 | T/C | 0.48 | 1.23 (1.11–1.38) | 1.69E-04 | 0.004 | 88.3 | 0.008 | 0.013 |
rs6944695 | EGFR | Intron | C/T | 0.50 | 0.93 (0.82–1.06) | 0.281 | C/T | 0.48 | 1.23 (1.10–1.37) | 2.21E-04 | 0.001 | 90.4 | 0.002 | 0.004 |
rs2075111 | EGFR | Intron | G/C | 0.50 | 0.93 (0.82–1.06) | 0.264 | G/C | 0.48 | 1.23 (1.10–1.37) | 2.21E-04 | 0.001 | 90.6 | 0.002 | 0.003 |
rs12718946 | EGFR | Intron | G/C | 0.42 | 0.91 (0.80–1.04) | 0.160 | G/C | 0.48 | 1.23 (1.10–1.37) | 1.86E-04 | 0.001 | 91.8 | 0.001 | 0.003 |
Abbreviations: MEC, Multiethnic/Minority Cohort Study of Diet and Cancer; PLCO, Prostate, Lung, Colorectal and Ovarian; BPC3, Breast and Prostate Cancer Cohort Consortium; EAF, effect allele frequency; OR, odds ratio; CI, confidence interval
Referring to “reference allele/effect allele”.
Meta-analysis of the two studies in each population. Logistic regression analysis was adjusted for age and principal components in each study.
Heterogeneity between results from the two racial groups were defined as Q-test P ≤ 0.100 or I2 ≥ 50.0%.
Meta-regression analysis of results from the four studies (MEC, Ghana, PLCO and BPC3) as independent datasets included the racial group as a moderator. Results of the four studies were shown in Supporting Information Table 6.
The multiplicative interaction of each SNP and racial group in logistic regression analysis was adjusted for age and racial group in a pooled dataset from the four studies with 2,753 cases and 3,666 controls.
All four studies used A as the effect allele for rs722921 in analyses of Q-test, I2, meta-regression and multiplicative interaction.